G Remuzzi Selected Research

G Remuzzi Research Topics

Disease

21	Proteinuria 02/2013 - 01/2000
15	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 01/2000
6	Type 2 Diabetes Mellitus (MODY) 01/2009 - 06/2000
5	Inflammation (Inflammations) 09/2017 - 01/2000
5	Thrombotic Microangiopathies 06/2013 - 10/2000
4	Thrombotic Thrombocytopenic Purpura 11/2009 - 01/2001
4	Hemolytic-Uremic Syndrome 08/2006 - 03/2001
4	Hypertension (High Blood Pressure) 11/2001 - 05/2000
4	Thrombosis (Thrombus) 09/2001 - 08/2000
4	Disease Progression 09/2001 - 01/2000
3	Infections 08/2013 - 01/2001
3	Atypical Hemolytic Uremic Syndrome 06/2013 - 11/2005
3	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2010 - 12/2000
3	Albuminuria 01/2009 - 05/2006
3	Chronic Renal Insufficiency 01/2004 - 01/2001
2	Acute Kidney Injury (Acute Renal Failure) 04/2014 - 03/2007
2	Renal Insufficiency (Renal Failure) 09/2012 - 01/2008
2	Skin Neoplasms (Skin Cancer) 07/2007 - 11/2000
2	Thrombocytopenia (Thrombopenia) 03/2007 - 01/2001
2	Lupus Nephritis 07/2006 - 08/2001
2	Heart Failure 10/2001 - 09/2001
1	Reperfusion Injury 09/2017
1	Ischemia 05/2014
1	Chronic Disease (Chronic Diseases) 06/2013
1	Meningococcal Infections 06/2013
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2009
1	Body Weight (Weight, Body) 01/2009
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 02/2008
1	Glomerulonephritis 02/2008
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2007
1	Carcinogenesis 07/2007
1	Basal Cell Carcinoma (Rodent Ulcer) 07/2007
1	Carcinoma (Carcinomatosis) 07/2007
1	Neoplasms (Cancer) 07/2007
1	Actinic Keratosis 07/2007
1	Hemolytic Anemia 03/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2006
1	Autoimmune Diseases (Autoimmune Disease) 07/2006
1	Sclerosis 04/2006
1	Kidney Diseases (Kidney Disease) 04/2006
1	Cytomegalovirus Infections (Inclusion Disease) 01/2004
1	Fabry Disease (Fabry's Disease) 12/2003
1	Atrophy 11/2001
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2001

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 08/2013 - 03/2000
10	CreatinineIBA 01/2016 - 05/2000
10	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009 - 01/2000
6	Complement System Proteins (Complement)IBA 09/2017 - 01/2001
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2006 - 01/2000
4	AlbuminsIBA 01/2016 - 03/2000
4	thiamine triphosphorate (TTP)IBA 11/2009 - 01/2001
4	Antihypertensive Agents (Antihypertensives)IBA 01/2009 - 03/2000
4	Losartan (Cozaar)FDA LinkGeneric 05/2006 - 12/2000
4	Angiotensin IIIBA 05/2006 - 12/2000
4	Ramipril (Altace)FDA LinkGeneric 01/2001 - 01/2000
3	Shiga Toxin (Shigella Toxin)IBA 07/2010 - 11/2005
3	Pharmaceutical PreparationsIBA 07/2006 - 01/2001
3	von Willebrand FactorIBA 09/2001 - 10/2000
2	Rituximab (Mabthera)FDA Link 05/2010 - 01/2001
2	CalciumIBA 01/2009 - 11/2001
2	Angiotensin Receptor AntagonistsIBA 01/2009 - 09/2001
2	Complement Factor H (Factor H)IBA 02/2008 - 03/2001
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2007 - 08/2001
2	SteroidsIBA 07/2006 - 08/2001
2	Lisinopril (Prinivil)FDA LinkGeneric 04/2006 - 12/2000
1	AntigensIBA 09/2017
1	SurvivinIBA 05/2014
1	Shiga Toxins (Vero Toxin)IBA 08/2013
1	Complement Inactivating AgentsIBA 06/2013
1	eculizumab FDA Link 06/2013
1	Complement C3 (C3 Complement)IBA 09/2012
1	Parathyroid Hormone (Parathormone)IBA 01/2009
1	paricalcitol (Zemplar)FDA Link 01/2009
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2009
1	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2007
1	3' Untranslated Regions (3' UTR)IBA 07/2007
1	ProstaglandinsIBA 07/2007
1	Aligeron (AS 2)IBA 10/2006
1	A-factor (Streptomyces)IBA 08/2006
1	Imatinib Mesylate (Gleevec)FDA Link 07/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2006
1	Tyrosine Kinase InhibitorsIBA 07/2006
1	Immunologic Factors (Immunomodulators)IBA 01/2004
1	Isoantigens (Alloantigen)IBA 01/2004
1	LipidsIBA 12/2003
1	lacidipineIBA 11/2001
1	Platelet Membrane GlycoproteinsIBA 09/2001
1	Abciximab (ReoPro)FDA Link 09/2001
1	Integrin alphaVbeta3IBA 09/2001
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 09/2001
1	P-SelectinIBA 09/2001
1	Aurintricarboxylic AcidIBA 09/2001
1	Thromboxane A2 (A2, Thromboxane)IBA 08/2001

Therapy/Procedure

15	Therapeutics 06/2013 - 01/2000
7	Kidney Transplantation 09/2017 - 07/2001
4	Transplantation 06/2009 - 11/2000
2	Plasma Exchange 06/2013 - 01/2008
2	Organ Transplantation 07/2007 - 01/2001
1	Enzyme Replacement Therapy 12/2003